Prevention of Stroke: Carotid Artery Stenting or Endarterectomy?

Original Title: Long-Term Outcome after Carotid Artery Stenting. A Population-Based Matched Cohort Study.

Reference: Stroke. 2016 Jul 12. [Epub ahead of print].

 

Carotid Artery Stenting EndarterectomyIn the prevention of stroke, carotid artery stenting (CAS) is far less invasive than endarterectomy, but its long term outcomes remain unclear.

This large cohort study compared the long term outcomes of CAS vs. endarterectomy.

All patients included in the Swedvasc registry (National Swedish Vascular Registry) treated with CAS between 2005 and 2012 were identified. For every CAS procedure, 2 control endarterectomy procedures were included, matched by:

 

  • sex
  • age
  • year of procedure
  • indication (symptomatic/asymptomatic).

Primary end point was ipsilateral stroke, or death 30 days after procedure.

A total 1157 patients were included (409 CAS and 748 endarterectomy). Median age was 70 and 69% were symptomatic.

Risk factors were similar in both groups and the population was followed up at mean 4.1 years.

Death or stroke rates beyond the 30 days perioperative period occurred in:

  • 95 of 394 CAS patients (25.7%)
  • 120 of 724 endarterectomy patients (18.6%)

[Adjusted risk 1.59; CI 95% 1.15–2.18]

Death rate was:

  • 25.7% with CAS
  • 18.6% with endarterectomy

[HR 1.20; CI 95% 0.84–1.72]

Ipsilateral stroke rate was:

  • 9.4% with CAS
  • 2.9% with endarterectomy

[HR 3.40; CI 95% 1.53–7.53]

Any stroke + death after 30 days was:

  • 34.2% with CAS
  • 23.6% with endarterectomy

[HR 1.49; CI 95% 1.10–2.00]

 

Conclusion

In this cohort study, CAS was associated with a long term increased risk of ipsilateral stroke and death after perioperative period compared to endarterectomy.

 

Editorial Comment

Even though population was matched, some characteristics may be misleading in this kind of studies. Higher mortality in the CAS group cannot be explained by excessive ipsilateral stroke and may be due to higher global risk, which may have favored CAS indication, being less invasive.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....